Anusha Kalbasi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Epstein Barr Virus

Top Venues

Cancer discovery

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Kayla R Kulhanek, Anusha Kalbasi
Targeted Bias: The Next Swing at IL2 Therapy. Cancer discovery 14 (7) (2024)
Kayla R Kulhanek, Anusha Kalbasi
Targeted Bias: The Next Swing at IL2 Therapy. Cancer discovery 14 (7) (2024)
Mi-Heon Lee, Duang Ratanachan, Zitian Wang, Jacob Hack, Lobna Adbulrahman, Nicholas P Shamlin, Mirna Kalayjian, Jean Philippe Nesseler, Ekambaram Ganapathy, Christine Nguyen, Josephine A Ratikan, Nicolas A Cacalano, David Austin, Robert Damoiseaux, Benjamin J DiPardo, Danielle S Graham, Anusha Kalbasi, James W Sayre, William H McBride, Dörthe Schaue
Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation. Journal of immunology (Baltimore, Md. : 1950) (2023)
Kyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, Serena Y Lofftus, Amit Kumar Jaiswal, Tasha L Lin, Chris Frias, Lucia Y Chen, Manando Nakasaki, Sarah M Dry, Joseph G Crompton, Fritz Christian Eilber, Dinesh S Rao, Anusha Kalbasi, Brian E Kadera
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers 15 (18) (2023)
Davis Y Torrejon, Mildred Galvez, Gabriel Abril-Rodriguez, Katie M Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comin-Anduix, Antoni Ribas
Antitumor Immune Responses in B2M-Deficient Cancers. Cancer immunology research (2023)
Joanne B Weidhaas, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P Raja, Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Mark Scholz, Donatello Telesca
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy. Journal for immunotherapy of cancer 10 (2) (2022)
Jomjit Chantharasamee, Karlton Wong, Pasathorn Potivongsajarn, Amir Qorbani, Neda Motamed, Sandra Brackert, Joshua Cohen, Bartosz Chmielowski, Anusha Kalbasi, Jianyu Rao, Scott Nelson, Arun Singh
Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma. Cancer medicine 11 (15) (2022)
Anusha Kalbasi, Mikko Siurala, Leon L Su, Mito Tariveranmoshabad, Lora K Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V Kremer, Amy L Sun, María Sofía Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C Rommel, Enrico Radaelli, Regina M Young, Warren J Leonard, Antoni Ribas, Carl H June, K Christopher Garcia
Potentiating adoptive cell therapy using synthetic IL-9 receptors. Nature 607 (7918) (2022)
Lawrence A Stern, Sharareh Gholamin, Ignacio Moraga, Xin Yang, Supraja Saravanakumar, Joseph R Cohen, Renate Starr, Brenda Aguilar, Vanessa Salvary, Jonathan C Hibbard, Anusha Kalbasi, Jennifer K Shepphird, James O'Hearn, K Christopher Garcia, Christine E Brown
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. Proceedings of the National Academy of Sciences of the United States of America 119 (33) (2022)
Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Sarah V Kremer, Katie M Campbell, Juan M Funes, Agustin Vega-Crespo, Giulia Parisi, Ameya Champekar, Christine Nguyen, Davis Y Torrejon, Daniel Sanghoon Shin, Jesse M Zaretsky, Robert D Damoiseaux, Daniel E Speiser, Pedro P López-Casas, Marisol Quintero, Antoni Ribas
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Science translational medicine 12 (565) (2021)
Luca F Valle, Nicholas Bernthal, Fritz C Eilber, Jacob E Shabason, Manpreet Bedi, Anusha Kalbasi
Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma. Sarcoma 2021 (2021)
Danielle S Graham, Ritchell van Dams, Nicholas J Jackson, Mykola Onyshchenko, Mark A Eckardt, Benjamin J DiPardo, Scott D Nelson, Bartosz Chmielowski, Jacob E Shabason, Arun S Singh, Fritz Christian Eilber, Anusha Kalbasi
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma. Cancers 12 (9) (2020)
Anusha Kalbasi, Antoni Ribas
Tumour-intrinsic resistance to immune checkpoint blockade. Nature reviews. Immunology 20 (1) (2019)
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, Jesse M Zaretsky, Theodore S Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J Quist, Alejandro J Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoña Comin-Anduix, Siwen Hu-Lieskovan, Cun-Yu Wang, Catherine S Grasso, Antoni Ribas
PAK4 inhibition improves PD-1 blockade immunotherapy. Nature cancer 1 (1) (2019)